Evidence map›Paper›PMID 31263276›Full record

ArticleNature immunology2019

The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis.

Irene Mattiola, Federica Tomay, Maria De Pizzol, Rita Silva-Gomes, Benedetta Savino, Tamara Gulic, Andrea Doni, Silvia Lonardi, Marie Astrid Boutet, Alessandra Nerviani and 14 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Imaging transcriptomics in basal cell carcinoma: Coupling in vivo tumor morphology with gene expression.JID innovations : skin science from molecules to population health · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Immune dysfunction in Alzheimer disease.Nature reviews. Neuroscience · 2026
    Review
  8. Microglial dectin-1/Frontiers in immunology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Synovial MS4A4A correlates with inflammation and counteracts response to corticosteroids in arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  16. Identification of crucial genes for polycystic ovary syndrome and atherosclerosis through comprehensive bioinformatics analysis and machine learning.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Article
  17. Microglial MS4A4A Protects against Epileptic Seizures in Alzheimer's Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  18. Review
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 8 countries.

Irene MattiolaHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Federica TomayHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Maria De PizzolHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Rita Silva-GomesHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Benedetta SavinoHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Tamara GulicHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Andrea DoniHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Silvia LonardiDepartment of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.
Marie Astrid BoutetCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Alessandra NervianiCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Roberta CarrieroHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Martina MolgoraHumanitas University, Pieve Emanuele, Italy.
Matteo StravalaciHumanitas University, Pieve Emanuele, Italy.
Diego MoroneHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Irina N ShalovaSingapore Immunology Network, Agency for Science, Technology & Research, Singapore, Singapore.
Yunquin LeeSingapore Immunology Network, Agency for Science, Technology & Research, Singapore, Singapore.
Subhra K BiswasSingapore Immunology Network, Agency for Science, Technology & Research, Singapore, Singapore.
Giovanna MantovaniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Endocrinology Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Marina SironiHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Costantino PitzalisCentre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID http://orcid.org/0000-0003-1326-5051
William VermiDepartment of Molecular and Translational Medicine, School of Medicine, University of Brescia, Brescia, Italy.
Barbara BottazziHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy.
Alberto MantovaniHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy. alberto.mantovani@humanitasresearch.it.ORCID http://orcid.org/0000-0001-5578-236X
Massimo LocatiHumanitas Clinical and Research Center, Scientific Institute for Research and Healthcare, Rozzano, Italy. massimo.locati@humanitasresearch.it.ORCID http://orcid.org/0000-0003-3077-590X
Humanitas University · ITAgency for Science, Technology and Research · SGQueen Mary University of London · GBUniversity of Brescia · ITUniversity of Milan · ITWashington University in St. Louis · US

Funding

European Research Council 669415Medical Research Council G0800648Versus Arthritis 20022Versus Arthritis 21890
6 · The paper itself

Abstract

The plasma membrane tetraspan molecule MS4A4A is selectively expressed by macrophage-lineage cells, but its function is unknown. Here we report that MS4A4A was restricted to murine and human mononuclear phagocytes and was induced during monocyte-to-macrophage differentiation in the presence of interleukin 4 or dexamethasone. Human MS4A4A was co-expressed with M2/M2-like molecules in subsets of normal tissue-resident macrophages, infiltrating macrophages from inflamed synovium and tumor-associated macrophages. MS4A4A interacted and colocalized with the β-glucan receptor dectin-1 in lipid rafts. In response to dectin-1 ligands, Ms4a4a-deficient macrophages showed defective signaling and defective production of effector molecules. In experimental models of tumor progression and metastasis, Ms4a4a deficiency in macrophages had no impact on primary tumor growth, but was essential for dectin-1-mediated activation of macrophages and natural killer (NK) cell-mediated metastasis control. Thus, MS4A4A is a tetraspan molecule selectively expressed in macrophages during differentiation and polarization, essential for dectin-1-dependent activation of NK cell-mediated resistance to metastasis.

Indexed as

AnimalsCell DifferentiationCell LineageDectin-1DexamethasoneHumansInterleukin-4Killer Cells, NaturalLectins, C-TypeLymphocyte ActivationMacrophage ActivationMacrophagesMembrane ProteinsMiceMice, Inbred C57BLMice, Inbred NODCLEC7A protein, humanDectin-1DexamethasoneIL4 protein, humanInterleukin-4Lectins, C-TypeMembrane ProteinsMS4A4A protein, human

Identifiers

PMID31263276
PMCPMC7176488
OpenAlexW2954400117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.